Radio and PodcastLive Radio & PodcastsLoading episode
Fetching episode details...
Radio and PodcastLive Radio & PodcastsRadio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & PodcastsPatients with refractory or high-risk myasthenia gravis (MG) respond poorly to conventional immunosuppressive therapy, requiring rescue therapies and often experiencing treatment toxicity. The study discussed in this pod...
Cyclophosphamide for myasthenia gravis: a comeback? is an episode from JNNP podcast by BMJ Group. Patients with refractory or high-risk myasthenia gravis (MG) respond poorly to conventional immunosuppressive therapy, requiring rescue therap...
This episode belongs to JNNP podcast.
Use the player on this page to stream the episode online.
Published Apr 17, 2025, 37:58 long, audio available.
Continue listening to more episodes from JNNP podcast.
Jun 16, 2025 - 46:18
Feb 13, 2025 - 26:38
Apr 17, 2024 - 39:42
Feb 19, 2024 - 40:02
Sep 22, 2023 - 27:45
Aug 8, 2023 - 30:15